Outcome measures in long COVID clinical trials: a review.
van Rhijn-Brouwer, Femke C C, de Canson, Chloé, VanDerNagel, Joanneke E L et al.·Frontiers in public health·2026
Researchers reviewed clinical trials for long COVID and ME/CFS to see what measures doctors and researchers use to track whether treatments work. They found that trials use many different outcome measures, and report that long COVID trials could be improved by better measuring specific symptoms like post-exertional malaise and dysautonomia, and by including what patients think matters most. This is an early review of current practices, not a definitive guide.